Kim Bum Soo, Joo Sun Hyung, Lee Suk Hwan, Lee Jung Il, Kim Hyun Cheol, Nam Deok Ho, Park Ho Chul
Department of Surgery, Kyung Hee University Gangdong Hospital, Kyung Hee University School of Medicine, Seoul, Korea.
J Korean Surg Soc. 2011 Jun;80 Suppl 1(Suppl 1):S51-4. doi: 10.4174/jkss.2011.80.Suppl1.S51. Epub 2011 Jun 17.
Adult-onset type II citrullinemia (CTLN2) is a disorder caused by an inborn error of metabolism affecting the liver. CTLN2 is an autosomal recessive disorder characterized by recurrent encephalopathy with hyperammonemia due to highly elevated plasma levels of citrulline and ammonia, caused by a deficiency of argininosuccinate synthetase in the liver. A small number of patients have undergone liver transplantation with favorable results. In Korea, the limitations of the deceased donor pool have made living donor liver transplantation a common alternative treatment option. We report the case of a patient with type II citrullinemia who was treated successfully with auxiliary partial orthotopic liver transplantation (APOLT) from a living donor. This is the first description of an APOLT for a patient with adult onset type II citrullinemia in Korea.
成人型II型瓜氨酸血症(CTLN2)是一种由影响肝脏的先天性代谢缺陷引起的疾病。CTLN2是一种常染色体隐性疾病,其特征为反复发作的脑病伴高氨血症,这是由于肝脏中精氨琥珀酸合成酶缺乏导致血浆瓜氨酸和氨水平大幅升高所致。少数患者接受了肝移植,效果良好。在韩国,已故供体库的限制使得活体供肝移植成为一种常见的替代治疗选择。我们报告了一例II型瓜氨酸血症患者,通过活体供体的辅助部分原位肝移植(APOLT)成功治愈。这是韩国首例关于成人型II型瓜氨酸血症患者接受APOLT的描述。